Key result
Pulmonary tumor thrombotic microangiopathy is a rare cause of pulmonary hypertension and right ventricular failure in cancer patients, treated with antineoplastic and vasodilator therapies.
Pulmonary tumor thrombotic microangiopathy is a rare cause of pulmonary hypertension in cancer patients that can present with right ventricular failure.
Answers are grounded in this paper and cite their sources.
Consider PTTM in cancer patients with unexplained PH and RV failure; leaves open optimal therapy pending prospective data.
Pulmonary tumor thrombotic microangiopathy is a rare cause of pulmonary hypertension in patients with cancer, and pathology demonstrates tumor cells occluding the pulmonary vasculature. Clinical presentation ranges from subacute to acute signs of right ventricular failure. Treatment centers on antineoplastic therapies, but the use of pulmonary vasodilator therapies also has been reported.
No takes yet. Share an insight, caveat, or question.
Li et al. (2023) studied this question. Pulmonary tumor thrombotic microangiopathy is a rare cause of pulmonary hypertension and right ventricular failure in cancer patients, treated with antineoplastic and vasodilator therapies.
Synapse has enriched 10 related papers. Consider them for comparative context: